Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ISRCTN41823570) titled 'A trial to assess if aspirin with omega-3 and colchicine are medicines that can help recovery from a COPD exacerbation' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Factorial
Purpose: Treatment
Primary Sponsor: Cambridge Clinical Trials Unit (CCTU)
Condition:
Chronic obstructive pulmonary disease (COPD)
Respiratory
Intervention:
2x2 factorial design trial. Participants will be randomised to of the following:
1. Aspirin 75mg with 1g omega-3 once daily
+placebo colchicine 500mcg every other day (alter...